Previous close | 124.84 |
Open | 125.04 |
Bid | 125.18 x 800 |
Ask | 125.05 x 1200 |
Day's range | 124.61 - 126.05 |
52-week range | 95.94 - 136.91 |
Volume | |
Avg. volume | 709,422 |
Market cap | 10.978B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | 20.49 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.92 (1.54%) |
Ex-dividend date | 13 Jun 2024 |
1y target est | N/A |
Weakness in the HST segment, the escalating cost of sales, rising selling, general and administrative expenses and forex woes are likely to hurt IDEX's (IEX) first-quarter performance.
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
Allegion (ALLE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.